Chelsie Word
Medical · Albuquerque, NMNPI 1952672057
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,503 and has fallen 64.1% since, to $540 in 2025. Among medical clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $23.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$632
- Regeneron Healthcare Solutions, Inc.$450
- Sanofi$371
- CSL Behring$355
- GSK$311
- Grifols USA, LLC$302
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,614100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $632 |
| Regeneron Healthcare Solutions, Inc. | 21 | $450 |
| Sanofi | 20 | $371 |
| CSL Behring | 15 | $355 |
| GSK | 14 | $311 |
| Grifols USA, LLC | 17 | $302 |
| Genentech USA, Inc. | 10 | $248 |
| Incyte Corporation | 13 | $232 |
| Amgen | 7 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $113 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $95 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $78 |
| Pharming Healthcare, Inc. | 3 | $57 |
| Biocryst US Sales Co., LLC | 3 | $57 |
| Blueprint Medicines Corporation | 2 | $46 |
| Medtronic | 1 | $27 |
| Mylan Specialty L.p. | 1 | $25 |
| Novartis | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Pfizer | 1 | $19 |
| Aerin Medical Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,614 in reported general payments places this provider in the 90th percentile of 156 medical providers in New Mexico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $43,265 |
| Arnuity ElliptaFluticasone Furoate | 16 | $7,078 |
| Epinephrine | 23 | $5,687 |
| Fluticasone Propionate HfaFluticasone Propionate | 11 | $4,963 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $4,763 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $4,430 |
| DuleraMometasone/Formoterol | 11 | $4,336 |
| Ipratropium Bromide | 133 | $3,184 |
| BreynaBudesonide/Formoterol Fumarate | 16 | $3,016 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 24 | $2,685 |
| Montelukast Sodium | 67 | $1,258 |
| Azelastine Hcl | 25 | $1,098 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 47 | $1,083 |
| Fluticasone Propionate | 32 | $877 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKArnuity Ellipta | $311 | $7,07816 claims |
| AstraZenecaSymbicort | $632 | $4,43015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 156 medical providers in New Mexico.
Other medical in Albuquerque
- Paul TapiaAlbuquerque$7K
- Niki NinopoulosAlbuquerque$7K
- Katie JoshiAlbuquerque$6K
- Loretta GonzalesAlbuquerque$5K
- Ruben FrancoAlbuquerque$4K
- Bradford GwytherAlbuquerque$4K
- Medhat El-SabawyAlbuquerque$3K
- Mohammad Al RaieAlbuquerque$3K
- Juanita FeuchterAlbuquerque$3K
- Jerome BacaAlbuquerque$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.